-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Bruker, Raises Price Target to $60

Benzinga·06/24/2026 14:28:04
Listen to the news
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $53 to $60.